Privia Health Group (PRVA) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 20, 2026, to be held virtually for stockholders of record as of March 23, 2026.

• Proxy materials, including the notice, proxy statement, and annual report, are available online, with options to request paper or email copies.

Voting matters and shareholder proposals

• Election of three Class I director nominees to serve until the 2029 annual meeting: Nancy Cocozza, David King, and Francis Soistman.

• Advisory vote to approve compensation of named executive officers.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2026.

• Board recommends voting FOR all nominees and proposals.

Board of directors and corporate governance

• Board composition includes at least three nominees up for election as Class I directors, with terms extending to 2029.